SAN FRANCISCO, Oct. 30, 2019 /PRNewswire/ -- The Global Allergy Immunotherapies Market is expected to witness a major overhaul in the years to come. This is attributed to inadequacy of traditional treatment interventions like pharmacotherapy. Allergy immunotherapy, better known as desensitization or hyposensitization, is getting popular as it cures loads of allergies by raising immunological tolerance. Immunotherapies do offer long-term cure and last even post allergy treatment.
Advertisement
Market Scope
The market for allergy immunotherapies is moving at an impressive rate. This could be due to rising consciousness amongst the patients regarding allergy treatment, development of new products, and growing number of allergy-infected patients. Allergy tablets did gain popularity conventionally after U.S. FDA allowed usage of SLIT (Sublingual Immunotherapy) tablets for curing grass pollen and ragweed allergies. These grass pollen allergy drugs are being used for reducing allergy symptoms. At the same time, the fact that allergy tablets are remedial with respect to only specific kind of allergen. This factor is restraining the market.
Advertisement
Market Trends
SCIT (subcutaneous immunotherapy) has been doing the rounds these days. The credit goes to its competency of modifying immune system and controlling growth of allergies. As per World Allergy Organization, pervasiveness of allergies has increased manifold. According to Summary Health Statistics for U.S. Adults, over 8% of adults all over the U.S. do suffer from hay fever and sinusitis. This is another factor driving the market for allergy immunotherapies.
Download PDF to know more details about "Global Allergy Immunotherapies Market" Report 2028.
Segmentation
The allergy immunotherapies market is segmented based on product and geography. By product, the market spans SLIT and SCIT. By geography, it comprises North America, Asia Pacific, Europe, MEA, and LATAM.
Players
The players contributing to the allergy immunotherapies market include Stallergenes Greer, Merck, HAL Allergy, and Allergy Therapeutics. Inorganic growth is being emphasized on. The future may witness mergers & acquisitions, partnerships, joint ventures, or collaborations in the near future. These efforts are in the direction of sustenance amidst competition.
This report provides detailed historical analysis of global market for Allergy Immunotherapies from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Allergy Immunotherapies market.
Access 103 page research report with TOC on "Global Allergy Immunotherapies Market" available with Radiant Insights, Inc. @: https://www.radiantinsights.com/research/2013-2028-report-on-global-allergy-immunotherapies-market
Market Segmentation:
- Leading players of Allergy Immunotherapies including:
- ALK-Abello
- Stallergenes Greer
- Merck
- Allergy Therapeutics
- HAL
- WOLW Pharma
- Holister Stier
- Leti
- Market split by Type, can be divided into:
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
- Market split by Application, can be divided into:
- Allergic Rhinitis
- Allergic Asthma
- Other
- Market split by Sales Channel, can be divided into:
- Direct Channel
- Distribution Channel
- Market segment by Region/Country including:
- North America (United States, Canada and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Spain etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
- South America Brazil, Argentina, Colombia and Chile etc.)
- Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)
- Sphygmomanometer Market
- Medical Hyperspectral Imaging Market
- Orthopedics Devices Market
- Cardiac Care Medical Equipments Market
At Radiant Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact:
Michelle ThorasCorporate Sales SpecialistRadiant Insights, Inc.Phone: +1-415-349-0054Toll Free: 1-888-928-9744Email: [email protected]Web: https://www.radiantinsights.com
View original content:http://www.prnewswire.com/news-releases/allergy-immunotherapies-market-analysis--potential-growth-opportunities-2028-with-key-players-alk-abello-merck-wolw-pharma-hal--leti--radiant-insights-inc-300947847.html
SOURCE Radiant Insights, Inc.
